Prohibiting Tianeptine and Other Dangerous Products Act of 2026
Prohibiting Tianeptine and Other Dangerous Products Act of 2026
Plain Language Summary
# Prohibiting Tianeptine and Other Dangerous Products Act of 2026 - Summary **What It Does:** This bill would prohibit the sale and distribution of tianeptine, a drug that is not currently approved by the FDA but is being sold in the U.S. under names like "Za Za Red" and "Tianna." Tianeptine is a prescription antidepressant in other countries but is marketed here as a dietary supplement or nootropic (cognitive enhancer). The bill aims to add tianeptine to the list of controlled substances, making it illegal to manufacture, possess, or sell without authorization. **Who It Affects:** The legislation would impact consumers who currently purchase tianeptine products, retailers and online sellers offering these products, and manufacturers distributing them. The bill also relates to concerns raised by public health officials, as tianeptine has potential for abuse and dependence, with some users reporting withdrawal symptoms similar to opioids. **Current Status:** As of now, the bill (S.
3797) is in committee and has not yet been voted on by the full Senate. It was introduced by Senator Richard J. Durbin (D-Illinois) during the 119th Congress. No further action has been reported.
Latest Action
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S512)